
Voglirux 0.3mg Tablet
Marketer
Aarux Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglirux 0.3mg Tablet
GlucoReg 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated post-prandial blood glucose. It's indicated when dietary modifications and other comparable therapies prove insufficient in controlling hyperglycemia. GlucoReg 0.3mg tablets should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize blood sugar management. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood glucose, potentially leading to severe complications such as renal impairment and visual disturbances. This medication is part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Common adverse effects include flatulence, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While GlucoReg 0.3mg tablets alone do not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Glucose should be administered to address hypoglycemic episodes; sucrose is ineffective in this context. Prior to initiating treatment, inform your physician of any hepatic or renal dysfunction. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all concurrent medications is crucial for patient safety. Excessive alcohol consumption should be avoided as it may increase the risk of hypoglycemia.
Uses of Voglirux 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglirux 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglirux 0.3mg Tablet on an empty stomach.
Common Side effects of Voglirux 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglirux 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Voglirux tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.
How Voglirux 0.3mg Tablet works:
Voglirux 0.3mg tablets manage blood sugar by suppressing enzymes in the intestines that digest complex carbohydrates. This action reduces postprandial hyperglycemia, preventing sharp spikes in blood glucose following meals.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglirux 0.3mg Tablet with alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglirux 0.3mg tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data from humans, the use of Voglirux 0.3mg tablets during breastfeeding is considered likely safe, with minimal anticipated risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglirux 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglirux 0.3mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglirux 0.3mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Voglirux 0.3mg Tablet :
Omit any missed Voglirux 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglirux 0.3mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Compound derived from valiolamine |
| Addictive | None. |
| Medication Classification | Medication for diabetes |
| Mechanism of Action | Agents that inhibit alpha-glucosidase |
